✦ LIBER ✦

CV8 THE COST-EFFECTIVENESS (COST-UTILITY) OF EPROSARTAN IN HYPERTENSIVE PATIENTS WITH CEREBROVASCULAR DISEASE IN BELGIUM, GERMANY, SPAIN, UNITED KINGDOM, AND SWEDEN

✍ Scribed by B Schwander; P Lindgren; B Gradl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Annual Cost of Dry Eye Syndrome in F

✍ Clegg, John P.; Guest, Julian F.; Lehman, Almut; Smith, Andrew F. 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 321 KB

PND15 THE COST-UTILITY OF EXELON PATCH I

✍ A Brennan; B Nagy; A Brandtmuller; SK Thomas; SD Sullivan; R Akehurst 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PND10 COST-EFFECTIVENESS STUDY IN PATIEN

✍ D Getsios; S Blume; KJ Ishak; G MacLaine 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PCV34 THE COST-EFFECTIVENESS OF ALISKIRE

✍ JL Palmer; VC Munk; R Kotchie; G Vincze; Charney k; D Tucker; L Annemans 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB